157 related articles for article (PubMed ID: 37855432)
41. Filamentous Bacteriophage-A Powerful Carrier for Glioma Therapy.
Wang Y; Sheng J; Chai J; Zhu C; Li X; Yang W; Cui R; Ge T
Front Immunol; 2021; 12():729336. PubMed ID: 34566987
[TBL] [Abstract][Full Text] [Related]
42. Liposomal Carrier Conjugated to APP-Derived Peptide for Brain Cancer Treatment.
Gabay M; Weizman A; Zeineh N; Kahana M; Obeid F; Allon N; Gavish M
Cell Mol Neurobiol; 2021 Jul; 41(5):1019-1029. PubMed ID: 33025416
[TBL] [Abstract][Full Text] [Related]
43. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
[TBL] [Abstract][Full Text] [Related]
44. Targeted delivery of nano-PTX to the brain tumor-associated macrophages.
Zou L; Tao Y; Payne G; Do L; Thomas T; Rodriguez J; Dou H
Oncotarget; 2017 Jan; 8(4):6564-6578. PubMed ID: 28036254
[TBL] [Abstract][Full Text] [Related]
45. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
[TBL] [Abstract][Full Text] [Related]
46. Targeted brain delivery nanoparticles for malignant gliomas.
Pinto MP; Arce M; Yameen B; Vilos C
Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
[TBL] [Abstract][Full Text] [Related]
47. Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma.
Wanjale MV; Kumar GSV
Expert Opin Drug Deliv; 2017 Jun; 14(6):811-824. PubMed ID: 27690671
[TBL] [Abstract][Full Text] [Related]
48. Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.
Liu HL; Yang HW; Hua MY; Wei KC
Neurosurg Focus; 2012 Jan; 32(1):E4. PubMed ID: 22208897
[TBL] [Abstract][Full Text] [Related]
49. Cell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma.
Zhang Y; Zhang L; Hu Y; Jiang K; Li Z; Lin YZ; Wei G; Lu W
J Control Release; 2018 Nov; 289():102-113. PubMed ID: 30243823
[TBL] [Abstract][Full Text] [Related]
50. Amino Acid Metabolism Abnormity and Microenvironment Variation Mediated Targeting and Controlled Glioma Chemotherapy.
An S; Lu X; Zhao W; Sun T; Zhang Y; Lu Y; Jiang C
Small; 2016 Oct; 12(40):5633-5645. PubMed ID: 27571928
[TBL] [Abstract][Full Text] [Related]
51. Construction of Functional Targeting Daunorubicin Liposomes Used for Eliminating Brain Glioma and Glioma Stem Cells.
Zhao WY; Zhang CX; Liu L; Mu LM; Zeng F; Ju RJ; Xie HJ; Yan Y; Zhao Y; Lu WL
J Biomed Nanotechnol; 2016 Jul; 12(7):1404-420. PubMed ID: 29336535
[TBL] [Abstract][Full Text] [Related]
52. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
[TBL] [Abstract][Full Text] [Related]
53. Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles.
Liang M; Gao C; Wang Y; Gong W; Fu S; Cui L; Zhou Z; Chu X; Zhang Y; Liu Q; Zhao X; Zhao B; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1652-1663. PubMed ID: 30394123
[TBL] [Abstract][Full Text] [Related]
54. Overcoming brain barriers through surface-functionalized liposomes for glioblastoma therapy; current status, challenges and future perspective.
Dong C; Yu X; Jin K; Qian J
Nanomedicine (Lond); 2023 Dec; 18(30):2161-2184. PubMed ID: 38180008
[TBL] [Abstract][Full Text] [Related]
55. D-T7 Peptide-Modified PEGylated Bilirubin Nanoparticles Loaded with Cediranib and Paclitaxel for Antiangiogenesis and Chemotherapy of Glioma.
Yu M; Su D; Yang Y; Qin L; Hu C; Liu R; Zhou Y; Yang C; Yang X; Wang G; Gao H
ACS Appl Mater Interfaces; 2019 Jan; 11(1):176-186. PubMed ID: 30525386
[TBL] [Abstract][Full Text] [Related]
56. Liposome-Based Systemic Glioma-Targeted Drug Delivery Enabled by All-d Peptides.
Ying M; Zhan C; Wang S; Yao B; Hu X; Song X; Zhang M; Wei X; Xiong Y; Lu W
ACS Appl Mater Interfaces; 2016 Nov; 8(44):29977-29985. PubMed ID: 27797175
[TBL] [Abstract][Full Text] [Related]
57. Penetrating the Blood-Brain Barrier by Self-Assembled 3D DNA Nanocages as Drug Delivery Vehicles for Brain Cancer Therapy.
Tam DY; Ho JW; Chan MS; Lau CH; Chang TJH; Leung HM; Liu LS; Wang F; Chan LLH; Tin C; Lo PK
ACS Appl Mater Interfaces; 2020 Jul; 12(26):28928-28940. PubMed ID: 32432847
[TBL] [Abstract][Full Text] [Related]
58. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
Li XY; Zhao Y; Sun MG; Shi JF; Ju RJ; Zhang CX; Li XT; Zhao WY; Mu LM; Zeng F; Lou JN; Lu WL
Biomaterials; 2014 Jul; 35(21):5591-604. PubMed ID: 24726749
[TBL] [Abstract][Full Text] [Related]
59. Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides.
Zhu Y; Jiang Y; Meng F; Deng C; Cheng R; Zhang J; Feijen J; Zhong Z
J Control Release; 2018 May; 278():1-8. PubMed ID: 29596873
[TBL] [Abstract][Full Text] [Related]
60. Liposomes Combined an Integrin αvβ3-Specific Vector with pH-Responsible Cell-Penetrating Property for Highly Effective Antiglioma Therapy through the Blood-Brain Barrier.
Shi K; Long Y; Xu C; Wang Y; Qiu Y; Yu Q; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
ACS Appl Mater Interfaces; 2015 Sep; 7(38):21442-54. PubMed ID: 26371468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
